Zeytin Pharma Private Limited
About Zeytin Pharma Private Limited
Data last updated:
Zeytin Pharma Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 21 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC314559. Its GSTIN is 27AABCZ2608P1ZV (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mosin Sattar Khatik and Sabir Ali Usman Ali Sayyed.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A/404 Rehmat Mahel Near Kausa Market Mumbra, Thane, Maharashtra, India – 400612.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.39 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹45,261 (net margin 0.3%) and EBITDA of ₹2.19 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 12% over five years.
Company details
Contact details
Zeytin Pharma Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressA/404 Rehmat Mahel Near Kausa Market Mumbra, Thane, Maharashtra, India – 400612
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Zeytin Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Zeytin Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Zeytin Pharma Private Limited, buy the company report.
Financials of Zeytin Pharma Private Limited
FY 2025 filings availableZeytin Pharma Private Limited reported revenue of ₹1.39 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 23% growth in the latest year. EBITDA fell 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45,261 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zeytin Pharma Private Limited, buy the company report.
Board of directors of Zeytin Pharma Private Limited
Zeytin Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mosin Sattar Khatik | Director | 21 Sep 2018 | 8 Years 1 Months | Current |
| Sabir Ali Usman Ali Sayyed Also directs: Incir Pharma Private Limited | Director | 21 Sep 2018 | 8 Years 1 Months | Current |
Peer comparison
Zeytin Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Exotic Rocks International Private Limited | ₹1.39 Cr (FY 2025) | 26.0% | Bangalore, Karnataka, India | |||
| Newton Firetech Systems Private Limited | ₹1.39 Cr (FY 2024) | 9.0% | New Delhi, Delhi, India | |||
| Bookish Bird Private Limited | ₹1.39 Cr (FY 2025) | -11.0% | Gwalior, Madhya Pradesh, India | |||
| Vijaystambh Traders Private Limited | ₹1.39 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Centum Nutrifoods Private Limited | ₹1.39 Cr (FY 2025) | 5.0% | Kovilpatti, Tamil Nadu, India | |||
| Zeytin Pharma Private Limitedthis company | ₹1.39 Cr (FY 2025) | ₹45,261 | 0.3% | 23.0% | Thane, Maharashtra, India | |
| Shr Prime Foods Private Limited | ₹1.39 Cr (FY 2025) | 10.0% | Bangalore, Karnataka, India | |||
| Joshi Papad Private Limited | ₹1.38 Cr (FY 2024) | -1.0% | Nashik, Maharashtra, India | |||
| Sr Fuel Mitra Private Limited | ₹1.38 Cr (FY 2025) | Lucknow, Uttar Pradesh, India | ||||
| Macaw Cibus India Private Limited | ₹1.38 Cr (FY 2025) | 0.0% | Delhi, India | |||
| Regene Healthcare Private Limited | ₹1.38 Cr (FY 2025) | 746.0% | Erode, Tamil Nadu, India |
To see the full peer comparison of Zeytin Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Zeytin Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Zeytin Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Zeytin Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCZ2608P1ZV | Maharashtra | Active | 24 Oct 2018 |
To see the full GST registrations and return filing status of Zeytin Pharma Private Limited, buy the company report.
Recent activity
Zeytin Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Mosin Sattar Khatik was appointed as Director on 21 Sep 2018.
Frequently asked questions
Zeytin Pharma is an active private limited company based in Thane, Maharashtra, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 21 September 2018 (8+ years old) and is registered under CIN U74999MH2018PTC314559.
Zeytin Pharma has 2 current directors:
- Mosin Sattar Khatik - Director
- Sabir Ali Usman Ali Sayyed - Director
The latest financial statements of Zeytin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Zeytin Pharma is 27AABCZ2608P1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Zeytin Pharma is U74999MH2018PTC314559. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zeytin Pharma was incorporated on 21 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Zeytin Pharma by revenue are Exotic Rocks International Private Limited, Newton Firetech Systems Private Limited, Bookish Bird Private Limited, Vijaystambh Traders Private Limited, Centum Nutrifoods Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Mosin Sattar Khatik was appointed as Director on 21 Sep 2018. Sabir Ali Usman Ali Sayyed was appointed as Director on 21 Sep 2018.
The registered office of Zeytin Pharma is at A404 Rehmat Mahel Near Kausa Market Mumbra, Thane, Maharashtra, India – 400612.
Zeytin Pharma operates in the business services industry, in the miscellaneous business activities segment.
Zeytin Pharma can be reached at its registered office: A404 Rehmat Mahel Near Kausa Market Mumbra, Thane, Maharashtra, India – 400612.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
